Aflac pres. Koide sells $1.7m in AFL stock By Investing.com

Aflac director Masatoshi Koide sold 15,431 shares on March 11, 2026 for $109.93 each, raising approximately $1.7M and leaving him with 86,422 shares; the sale was executed under a Rule 10b5-1 plan adopted Dec 5, 2025. Aflac reported Q4 2025 EPS of $1.57 versus a $1.70 consensus (−7.65% surprise) while revenue beat at $4.87B vs $4.28B (+13.79%). Mizuho nudged its price target to $107 from $104 but kept an Underperform rating and expects a roughly −6% return, underscoring mixed sentiment despite the revenue beat.

Analysis

The market reaction is conflating an operational margin signal with idiosyncratic liquidity activity; the former is meaningful (claims, expense or reserve pressure) while the latter has limited informational content when executed under pre‑planned 10b5‑1 frameworks. That distinction matters because near‑term multiple compression driven by sentiment can overshoot fundamental repricings tied to investment income and currency translation, both of which operate on multi‑quarter cadences and can materially swing reported EPS volatility.

Second‑order winners are firms with similar insurance flows but less concentrated Japan equity/currency translation exposure — they pick up index/ETF flows as allocators de‑emphasize Aflac‑specific risk without altering duration or credit stance. Conversely, reinsurers and specialty carriers could see margin relief if primary carriers bolster reinsurance purchases to stabilize reserving, shifting loss costs and capital allocation across the sector over the next 2–6 quarters.

Key catalysts that will reprice the stock are (1) FX moves out of Japan — a sustained yen move can retranslate earnings sharply within a quarter, (2) quarterly reserve commentary and underlying loss ratio trends over the next two prints, and (3) broader moves in the long‑end that change expected investment income; any one can reverse the current sentiment within 1–3 months. Tail risks include a catastrophic claims wave or regulatory action in Japan that would extend underperformance into years, while a persistent rise in yields is the primary near‑term upside scenario the market may be under‑estimating.

Key Decisions for Investors

• Short AFL via a 3‑month put spread to create a defined‑risk bearish position (buy near‑ATM 3M puts, sell 1.5–2x OTM 3M puts) sized to 1–2% of portfolio; target payoff if shares gap down 10–25% on follow‑through reserve or FX weakness, with maximum loss limited to premium paid (reward typically 2–4x premium).
• Pair trade (6–12 months): dollar‑neutral short AFL / long PRU or MET to isolate Japan/currency/execution risk; size the pair so beta to US rates is neutralized. Expect outperformance of the long by 10–20% if Aflac’s margin story persists; risk is a macro‑driven re‑rating that lifts both names.
• Tactical reallocate: trim Aflac exposure and redeploy into higher‑momentum, higher‑convexity ideas (e.g., SMCI) on a 1–3 month horizon — use proceeds to buy 1–3 month calls or outright exposure in the replacement name. This captures short‑term alpha while maintaining overall portfolio insurance exposure.
• Macro hedge: buy modest JPY call options (or enter FX forwards) with a 3–6 month tenor to protect against a yen appreciation scenario that would worsen translated earnings; cost should be sized as a de‑risking expense (~0.25–0.5% portfolio tilt) against the short AFL exposure.